The Anagrelide Hydrochloride Capsule Market is experiencing a steady surge in demand, driven by the growing prevalence of thrombocythemia and increased awareness about hematologic disorders. As this rare blood condition becomes more widely diagnosed, healthcare providers are increasingly turning to anagrelide hydrochloride capsules as a reliable first-line treatment.